Innate Pharma S.A. (NASDAQ:IPHA) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Innate Pharma Full Year 2024 Financial Results and Business Update. All lines have been placed on mute to prevent any background noise.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Citadel Investment Group Ken Griffin | 11,853 | $21,928 | -45% | 0% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 3,975 | $2,233 | 0.01% | |
2. | 675 | $1,200 | 0% |